FDA — authorised 14 January 1960
- Marketing authorisation holder: LEDERLE
- Status: approved
🇺🇸 Demethylchlortetracycline in United States
FDA authorised Demethylchlortetracycline on 14 January 1960
Marketing authorisations
FDA — authorised 27 February 2008
- Application: ANDA065425
- Marketing authorisation holder: AMNEAL PHARM
- Status: approved
FDA — authorised 18 August 2015
- Application: ANDA065447
- Marketing authorisation holder: EPIC PHARMA LLC
- Status: approved
Demethylchlortetracycline in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Demethylchlortetracycline approved in United States?
Yes. FDA authorised it on 14 January 1960; FDA authorised it on 27 February 2008; FDA authorised it on 18 August 2015.
Who is the marketing authorisation holder for Demethylchlortetracycline in United States?
LEDERLE holds the US marketing authorisation.